Skip to content
MarketScale
‹ Back to IndustriesHealthcare

THREE PREDICTIONS FOR THE INTERNET OF MEDICAL THINGS

The Internet of Medical Things is revolutionizing healthcare, and Sunrise Labs is at the forefront of product development for medical devices and life science instrumentation. Technological achievements have long propelled the healthcare industry forward, with advancements in surgical robotics and electronic health records enhancing care for today’s patients. The current medical landscape is evolving as…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

The Internet of Medical Things is revolutionizing healthcare, and Sunrise Labs is at the forefront of product development for medical devices and life science instrumentation.

Technological achievements have long propelled the healthcare industry forward, with advancements in surgical robotics and electronic health records enhancing care for today’s patients. The current medical landscape is evolving as a result of the Internet of Things (IoT) which is helping to improve the patient experience, streamline operations, reduce human errors, and decrease costs. In healthcare, IoT devices commonly include wireless technologies that clinicians leverage to collect and analyze actionable patient data, then use this data to create better and more specialized treatment plans. IoT devices hold great promise for the future of medicine. Here are three predictions for the Internet of Medical Things.

1.) A NETWORK OF INTEGRATED DEVICES:

Current IoT devices work in a self-contained, independent fashion, but the trend is toward an entire network of connections. The network will integrate a catalog of devices including sensors, wearables, mobile apps, smart pills, and measurement tools like digital scales and thermometer, all gathering and transmitting data into a central system for deeper analysis. With access to a plethora of real-time data that can be connected to electronic health records, clinicians will be able to form proactive strategies to improve patient care.

2.) FASTER, MORE ACCURATE DIAGNOSES:

Smart, Internet-connected wearables will help physicians improve the speed and accuracy of diagnoses. Performing tests to deduce the source of an illness involves some trial-and-error and can prove time-intensive, which not all patients can afford. Wearable health monitoring devices can remotely and continuously feed large quantities of data to a hub for manual or automated analysis. The analysis and insights will provide healthcare practitioners with a holistic picture of a patient’s health and may even help non-invasively diagnose an illness in real-time, which could mean the difference between life and death for some.

3.) BETTER ILLNESS PREVENTION AND TREATMENTS:

The best cure is prevention, and wearable health technologies will allow clinicians to help patients develop personalized illness prevention strategies to improve their overall health. When treatment is necessary, expect healthcare providers to increasingly recommend smart pills, smart inhalers, smart blood glucose monitors, and other smart ‘connected’ medical devices that can lead to better adherence rates when compared to their stand alone counterparts.

The Internet of Medical Things is revolutionizing healthcare, and Sunrise Labs is at the forefront of product development for medical devices and life science instrumentation. Our approach for developing connected devices includes architecting a solution with defined requirements, cloud connectivity and database creation, app development, and addressing cybersecurity risk through a comprehensive risk assessment.

Click here to learn more about our expertise in this space.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512